Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview


« Back to Dashboard

Which patents cover Mesalamine, and what substitute generic drugs are available?

Mesalamine is a drug marketed by G And W Labs Inc, Perrigo Israel, and Mylan Pharms Inc. and is included in three NDAs.

The generic ingredient in MESALAMINE is mesalamine. There are twenty-six drug master file entries for this compound. Twenty-one suppliers are listed for this compound. There is one tentative approval for this compound. Additional details are available on the mesalamine profile page.

Summary for Tradename: MESALAMINE

Suppliers / Packagers: see list1
Bulk Api Vendors: see list112
Clinical Trials: see list26
Patent Applications: see list8,045
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:MESALAMINE at DailyMed

Pharmacology for Tradename: MESALAMINE

Ingredient-typeAminosalicylic Acids
Drug ClassAminosalicylate
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
G And W Labs Inc
ENEMA;RECTAL076841-001Sep 30, 2004RXNoNo► Subscribe► Subscribe
Perrigo Israel
ENEMA;RECTAL076751-001Sep 17, 2004RXNoNo► Subscribe► Subscribe
Mylan Pharms Inc
SUPPOSITORY;RECTAL204354-001Nov 24, 2015RXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.